JP Morgan Chase &CO. has cut its long position in Shanghai F...
JP Morgan Chase &CO. has cut its long position in Shanghai Fosun Pharmaceutical to 4.35% on May 24 from 5.1%. Add GanFeng Lithium to 6.1% from 5.35%, according to the HKEX filings.
$FOSUN PHARMA (02196.HK)$
$FOSUN INTL (00656.HK)$
$GANFENGLITHIUM (01772.HK)$
$JPMorgan (JPM.US)$
$FOSUN PHARMA (02196.HK)$
$FOSUN INTL (00656.HK)$
$GANFENGLITHIUM (01772.HK)$
$JPMorgan (JPM.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Twitter@Sino_Market | Realtime Chinese market info provider.
9474Followers
4Following
8973Visitors
Follow
Shi 0 : According to documents disclosed by the Hong Kong Stock Exchange, J.P. Morgan Chase's shareholding ratio in Fosun Pharmaceuticals (02196.HK) increased from 4.34% to 5.11% on June 1.